Search - tctmd.com

Displaying 161 - 180 of 336

Sort: Relevancy | Date

News Daily News

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Yael L. Maxwell

February 17, 2022

News Daily News

Chinese Herbal Formula Matches Losartan in Patients With Mild Hypertension

Caitlin E. Cox

February 11, 2022

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Michael O'Riordan

February 10, 2022

News Daily News

Before and After PCI, Women Have Poorer Health Status Than Men

L.A. McKeown

January 28, 2022

News Daily News

Consider COVID-19 History in Pre-op CV Screening, Doctors Say

Todd Neale

January 14, 2022

News Daily News

Ad Hoc PCI Outcomes Similar No Matter Who Does the Diagnostic Cath

Todd Neale

January 04, 2022

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2021

Caitlin E. Cox

December 29, 2021

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Daily News

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

Michael O'Riordan

December 23, 2021

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Daily News

Discharge Safe as Early as a Day After Primary PCI for STEMI

L.A. McKeown

December 15, 2021

News Daily News

Another Study Links Stopping Statins to MACE in the Elderly

Shelley Wood

December 03, 2021

News Opinion CV Team Dispatch

December 2021 News Roundup

L.A. McKeown

December 01, 2021

News Conference News AHA 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

Todd Neale

November 15, 2021

News Conference News TCT 2021

Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes

Yael L. Maxwell

November 09, 2021

News Daily News

New Chest Pain Guidelines Out at Last: Most Tests Have a Role

Michael O'Riordan

October 28, 2021

News Conference News TCT 2021

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

L.A. McKeown

October 22, 2021

News Conference News TCT 2021

Good Long-term Results With FANTOM BVS, but More Data Needed

Michael O'Riordan

October 21, 2021

News Conference News TCT 2021

No Harm From Thrombolytics in SCAD Patients With STEMI

Michael O'Riordan

October 13, 2021

News Conference News ESC 2021

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Michael O'Riordan

September 02, 2021

Advertisement

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Chinese Herbal Formula Matches Losartan in Patients With Mild Hypertension

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Before and After PCI, Women Have Poorer Health Status Than Men

Consider COVID-19 History in Pre-op CV Screening, Doctors Say

Ad Hoc PCI Outcomes Similar No Matter Who Does the Diagnostic Cath

TCTMD’s Top 10 Most Popular Stories for December 2021

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Discharge Safe as Early as a Day After Primary PCI for STEMI

Another Study Links Stopping Statins to MACE in the Elderly

December 2021 News Roundup

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes

New Chest Pain Guidelines Out at Last: Most Tests Have a Role

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

Good Long-term Results With FANTOM BVS, but More Data Needed

No Harm From Thrombolytics in SCAD Patients With STEMI

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content